+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Delivery Systems Market by Delivery Type, Formulation, Drug Release Mechanism, Application, End-User - Global Forecast 2025-2030- Product Image
Drug Delivery Systems Market by Delivery Type, Formulation, Drug Release Mechanism, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Drug Delivery Systems Market by Delivery Type, Formulation, Drug Release Mechanism, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6013573
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Delivery Systems Market grew from USD 37.04 billion in 2023 to USD 39.02 billion in 2024. It is expected to continue growing at a CAGR of 5.70%, reaching USD 54.61 billion by 2030.

The drug delivery systems market encompasses technologies and methods designed to transport therapeutic agents into the body efficiently and safely. These systems aim to enhance drug bioavailability, improve patient compliance, and reduce side effects by controlling the release and targeting specific sites. Necessitated by the growing prevalence of chronic diseases, advancements in biotechnology, and the need for targeted therapies, their application spans across fields like oncology, immunology, and neurology. End-users include hospitals, research institutes, and pharmaceutical companies, seeking to innovate and optimize therapeutic outcomes. Key growth factors include the increasing adoption of smart and nanotechnology-based delivery systems and the rising demand for biologics and biosimilars that require precise delivery mechanisms. Additionally, the burgeoning development of personalized medicine presents a pivotal opportunity for the market. Companies could leverage advancements in AI and machine learning to develop novel delivery systems that cater to individual patient requirements. However, challenges like high developmental costs, stringent regulatory requirements, and complexities in design and compatibility limit market growth. Furthermore, the industry faces hurdles in integrating new technologies with existing medical infrastructures. Among the optimal areas for innovation are the design of biodegradable polymers for controlled release, research on microencapsulation techniques, and exploration of multifunctional nanocarriers. Insights suggest a market that is moderately competitive, with significant opportunities for differentiation through technological breakthroughs. Businesses should focus on collaborations with academic institutions and investment in R&D for next-generation delivery systems to stay ahead. Additionally, expanding into emerging markets can catalyze growth due to the increasing healthcare infrastructure in these regions. In conclusion, while the drug delivery systems market presents challenges, proactive investments into research and strategic partnerships can be pivotal in capturing emerging opportunities.

Understanding Market Dynamics in the Drug Delivery Systems Market

The Drug Delivery Systems Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing prevalence of chronic & infectious diseases across the globe
    • Rising investment government support for healthcare infrastructure
    • Upsurge in the demand for personalized medicine
  • Market Restraints
    • High cost associated with development of drug delivery systems
  • Market Opportunities
    • Technological advancements in the production of drug delivery systems
    • Growing adoption of nanotechnology for efficient targeted drug delivery systems
  • Market Challenges
    • Regulatory hurdles and time-consuming approval processes

Exploring Porter’s Five Forces for the Drug Delivery Systems Market

Porter’s Five Forces framework further strengthens the insights of the Drug Delivery Systems Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Drug Delivery Systems Market

External macro-environmental factors deeply influence the performance of the Drug Delivery Systems Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Drug Delivery Systems Market

The Drug Delivery Systems Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Drug Delivery Systems Market

The Drug Delivery Systems Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Drug Delivery Systems Market

The Drug Delivery Systems Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Systems Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AptarGroup, Inc., AstraZeneca Plc, Boston Scientific Corporation, Cospheric LLC, DelSiTech Ltd., Enable Injections, Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Merit Medical Systems, Inc., Novartis AG, Pacira BioSciences, Inc., Pfizer Inc., Polysciences Inc., Sanofi S.A., SHL Medical, Societal CDMO by CoreRx, Inc., Terumo Corporation, Thermo Fisher Scientific Inc., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Delivery Type
    • Inhalation Drug Delivery
    • Injection-Based Delivery
    • Nasal Drug Delivery
    • Ocular Drug Delivery
    • Oral Drug Delivery
    • Topical Drug Delivery
    • Transdermal Drug Delivery
  • Formulation
    • Gas
    • Liquid
    • Semisolid
    • Solid
  • Drug Release Mechanism
    • Controlled Release
    • Immediate Release
    • Sustained Release
    • Targeted Release
  • Application
    • Cardiovascular Diseases
    • Central Nervous System Disorders
    • Diabetes
    • Infectious Diseases
    • Oncology
    • Respiratory Diseases
  • End-User
    • Diagnostic Centers
    • Home Care Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic & infectious diseases across the globe
5.1.1.2. Rising investment government support for healthcare infrastructure
5.1.1.3. Upsurge in the demand for personalized medicine
5.1.2. Restraints
5.1.2.1. High cost associated with development of drug delivery systems
5.1.3. Opportunities
5.1.3.1. Technological advancements in the production of drug delivery systems
5.1.3.2. Growing adoption of nanotechnology for efficient targeted drug delivery systems
5.1.4. Challenges
5.1.4.1. Regulatory hurdles and time-consuming approval processes
5.2. Market Segmentation Analysis
5.2.1. Delivery Type: Growing adoption transdermal drug delivery to ensure prolonged and controlled drug release
5.2.2. Application: Growing prevalence of diabetes globally push need for continuous drug delivery system
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Drug Delivery Systems Market, by Delivery Type
6.1. Introduction
6.2. Inhalation Drug Delivery
6.3. Injection-Based Delivery
6.4. Nasal Drug Delivery
6.5. Ocular Drug Delivery
6.6. Oral Drug Delivery
6.7. Topical Drug Delivery
6.8. Transdermal Drug Delivery
7. Drug Delivery Systems Market, by Formulation
7.1. Introduction
7.2. Gas
7.3. Liquid
7.4. Semisolid
7.5. Solid
8. Drug Delivery Systems Market, by Drug Release Mechanism
8.1. Introduction
8.2. Controlled Release
8.3. Immediate Release
8.4. Sustained Release
8.5. Targeted Release
9. Drug Delivery Systems Market, by Application
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Central Nervous System Disorders
9.4. Diabetes
9.5. Infectious Diseases
9.6. Oncology
9.7. Respiratory Diseases
10. Drug Delivery Systems Market, by End-User
10.1. Introduction
10.2. Diagnostic Centers
10.3. Home Care Settings
10.4. Hospitals & Clinics
11. Americas Drug Delivery Systems Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Drug Delivery Systems Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Drug Delivery Systems Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Schott Pharma and Koru Medical Systems Partner to Innovate Drug Delivery for Improved Patient Care
14.3.2. Difgen Boosts Production and Quality with Acquisition of FDA-Registered Facility
14.3.3. Sharps Technology Launches New Drug Delivery Systems to Enhance Patient Safety and Reduce Administration Risks
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. DRUG DELIVERY SYSTEMS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DRUG DELIVERY SYSTEMS MARKET DYNAMICS
TABLE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INHALATION DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTION-BASED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TOPICAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SEMISOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TARGETED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 54. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 55. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 60. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 80. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 81. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 82. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 85. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 86. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 87. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 95. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 96. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 97. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 101. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 105. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 106. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 107. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 110. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 111. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 112. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 115. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 116. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 117. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 120. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 122. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 125. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 126. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 127. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 130. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 131. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 132. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 140. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 141. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 142. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 143. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 146. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 147. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 148. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 151. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 153. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 156. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 158. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 161. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 162. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 163. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 166. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 167. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 168. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 171. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 173. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 186. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 187. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 188. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 191. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 192. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 193. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 196. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 197. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 198. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 217. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 218. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 231. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 232. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 233. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 246. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Drug Delivery Systems market, which are profiled in this report, include:
  • Abbott Laboratories
  • AptarGroup, Inc.
  • AstraZeneca Plc
  • Boston Scientific Corporation
  • Cospheric LLC
  • DelSiTech Ltd.
  • Enable Injections, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Merit Medical Systems, Inc.
  • Novartis AG
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Polysciences Inc.
  • Sanofi S.A.
  • SHL Medical
  • Societal CDMO by CoreRx, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • West Pharmaceutical Services, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 39.02 Billion
Forecasted Market Value ( USD ) by 2030 $ 54.61 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Global Controlled Release Drug Delivery Market by Release Mechanism (Activation-Modulated Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems), Technology (Coacervation, Implants, Micro Encapsulation), Application - Forecast 2024-2030 - Product Image

Global Controlled Release Drug Delivery Market by Release Mechanism (Activation-Modulated Drug Delivery Systems, Chemically Activated, Feedback Regulated Drug Delivery Systems), Technology (Coacervation, Implants, Micro Encapsulation), Application - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report, By Technology (Targeted Delivery, Transdermal), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2023-2030 - Product Image

Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report, By Technology (Targeted Delivery, Transdermal), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 120 Pages
  • Global
From
Buccal Drug Delivery Systems Market by Type, Application, End-user - Global Forecast 2025-2030 - Product Image

Buccal Drug Delivery Systems Market by Type, Application, End-user - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Global Novel Drug Delivery Systems Market by Route of Administration, Mode, End-User - Forecast 2024-2030 - Product Image

Global Novel Drug Delivery Systems Market by Route of Administration, Mode, End-User - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.